Publication in Diabetes, Obesity and Metabolism on prediction of mortality and major cardiovascular complicationsin type 2 diabetes

New publication, reporting work on the @IMI_Rhapsody project: External validation of UKPDS Outcomes Model V2 in two European observational cohorts. Click here to read it.

RHAPSODY project new webpages

Learn about the latest research into Precision Therapy and Prevention of #Diabetes on the brand new Rhapsody project webpages @IMI_JU @EFPIA 

Presentation of RHAPSODY in Endocrinology, Diabetes & Metabolism

"RHAPSODY, Biomarkers and Novel Clinical Trial design in type 2 diabetes (T2D) and prediabetes", a collaborative work between Janssen and ULUND resulting in a comprehensive 10 Minutes tutorial just published in Endocrinology, Diabetes & Metabolism

The Complex Bidirectional Relationship between Covid-19 and Diabetes

A publication from the UOXF team discussing the potential mechanisms through which diabetes may affect the risk of more severe outcomes in Covid-19 and how diabetic emergencies and longer term pathology may be aggravated by infection with the virus. Read the article.

RHAPSODY 5th Consortium Meeting

Today took place the 5th RHAPSODY Consortium Meeting. An unusual online format that didn't affect the quality of the scientific exchanges. Despite the difficult conditions of the last few months the project remains on track.
One year before the end of the project we took stock of the results so far and discussed the necessary steps for a successful project conclusion.

Show more posts

Stacks Image 47
Stacks Image 398
Stacks Image 51
Stacks Image 349
This project receives funding from the Innovative Medicines Initiative 2 Joint Undertaking (www.imi.europa.eu) under grant agreement No 115881. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

This work is supported by the Swiss State Secretariat for Education‚ Research and Innovation (SERI) under contract number 16.0097-2.

The opinions expressed and arguments employed herein do not necessarily reflect the official views of these funding bodies.